Current Members
Postdoctoral positions are open: learn more.
Rotation Positions for PhD and MD/PhD students are available.
-
Andrei A. Korostelev, Ph.D.
Programs: Current member
Professor. Curriculum vitae (PDF)
RNA Therapeutics Institute
UMass Chan Medical School
andrei.korostelev@umassmed.edu -
William Cruz, M.S.
Programs: Current member
Graduate student
William.Cruz@umassmed.eduWill earned both his bachelor’s and master’s degrees in chemistry from California State Polytechnic University, Pomona. In 2023, he joined the Korostelev lab, where his research focuses on the protein kinase General Control Nonderepressible 2 (GCN2). Outside of the lab, Will enjoys learning new languages, cooking, baking, and trying new foods. Since relocating from California to Massachusetts, he has particularly enjoyed hiking Mount Wachusett and highly recommends it for anyone looking for a stunning view of central Massachusetts.
-
Stephen Diggs, Ph.D.
Programs: Current member
Postdoctoral Researcher
stephen.diggs@umassmed.edu -
Dmitrij Golovenko, Ph.D.
Programs: Current member
Postdoctoral Researcher
Dmitrij.Golovenko@umassmed.edu -
Chun-Ying Huang, B.S.
Programs: Current member
Graduate Student
ChunYing.Huang2@umassmed.edu -
Isabelle (Izzy) Loop, B.S.
Programs: Current member
Research Associate
Isabelle.Loop@umassmed.edu -
Anna B. Loveland, Ph.D.
Programs: Current member
Assistant Professor
Anna.Loveland@umassmed.eduDr. Loveland is an Assistant Professor at the RNA Therapeutics Institute at UMass Chan Medical School. She earned her B.A. in Biophysics from Johns Hopkins University and her Ph.D, also in Biophysics, from Harvard University in 2012. As a Helen Hay Whitney post-doctoral fellow, she found her calling in structural biology while working with Profs. Niko Grigorieff, Melissa Moore, and Andrei Korostelev at Brandeis University and later UMass Medical School. Her post-doctoral work with Dr. Korostelev on the mechanism of tRNA decoding was awarded an RNA Society Scaringe Young Scientist Award in 2021. Dr. Loveland investigates molecular mechanisms at the intersection of translation and disease utilizing cryo-EM and biochemical approaches. She currently focuses on two, distinct genes associated with amyotrophic lateral sclerosis, C9orf72 and Angiogenin, whose products, unexpectedly, bind the ribosome and inhibit translation. She seeks a deeper understanding of the molecular mechanism of these proteins and their mutations to spur new therapeutics development.
-
Zahra Seraj, Ph.D.
Programs: Current member
Postdoctoral Researcher
zahra.seraj@umassmed.edu -
Emily Sholi, B.S.
Programs: Current member
Graduate student
Emily.Sholi@umassmed.edu -
Denis Susorov, Ph.D.
Programs: Current member
Postdoctoral Researcher
denis.susorov@umassmed.edu
Updated on September 10, 2024